Lördag 7 Februari | 22:40:56 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2026-05-28 N/A Årsstämma
2026-02-19 08:30 Bokslutskommuniké 2025
2025-12-16 - Extra Bolagsstämma 2025
2025-08-28 - Kvartalsrapport 2025-Q2
2025-06-12 - X-dag ordinarie utdelning HEART 0.00 SEK
2025-06-11 - Årsstämma
2025-05-15 - Kvartalsrapport 2025-Q1
2025-02-26 - Bokslutskommuniké 2024
2024-11-21 - Split HEART 100:1
2024-11-14 - Kvartalsrapport 2024-Q3
2024-11-05 - Extra Bolagsstämma 2024
2024-08-22 - Kvartalsrapport 2024-Q2
2024-06-10 - X-dag ordinarie utdelning HEART 0.00 SEK
2024-06-07 - Årsstämma
2024-05-08 - Kvartalsrapport 2024-Q1
2024-02-15 - Bokslutskommuniké 2023
2023-11-24 - Extra Bolagsstämma 2023
2023-11-16 - Kvartalsrapport 2023-Q3
2023-08-24 - Kvartalsrapport 2023-Q2
2023-06-16 - Årsstämma
2023-06-15 - X-dag ordinarie utdelning HEART 0.00 SEK
2023-06-14 - Årsstämma
2023-05-11 - Kvartalsrapport 2023-Q1
2023-02-24 - Bokslutskommuniké 2022
2022-11-18 - Kvartalsrapport 2022-Q3
2022-08-19 - Kvartalsrapport 2022-Q2
2022-06-15 - X-dag ordinarie utdelning HEART 0.00 SEK
2022-06-14 - Årsstämma
2022-05-20 - Kvartalsrapport 2022-Q1
2022-02-24 - Bokslutskommuniké 2021
2021-11-18 - Kvartalsrapport 2021-Q3
2021-08-19 - Kvartalsrapport 2021-Q2
2021-08-05 - Extra Bolagsstämma 2021
2021-05-20 - Kvartalsrapport 2021-Q1
2021-05-03 - X-dag ordinarie utdelning HEART 0.00 SEK
2021-02-25 - Bokslutskommuniké 2020
2020-11-19 - Kvartalsrapport 2020-Q3
2020-08-20 - Kvartalsrapport 2020-Q2
2020-08-04 - Extra Bolagsstämma 2020
2020-05-20 - Kvartalsrapport 2020-Q1
2020-05-19 - X-dag ordinarie utdelning HEART 0.00 SEK
2020-05-18 - Årsstämma
2020-02-27 - Bokslutskommuniké 2019
2019-11-21 - Kvartalsrapport 2019-Q3
2019-08-22 - Kvartalsrapport 2019-Q2
2019-05-23 - Kvartalsrapport 2019-Q1
2019-03-27 - X-dag ordinarie utdelning HEART 0.00 SEK
2019-03-26 - Årsstämma
2019-02-27 - Bokslutskommuniké 2018
2018-11-22 - Kvartalsrapport 2018-Q3
2018-08-23 - Kvartalsrapport 2018-Q2
2018-05-24 - Årsstämma
2018-05-17 - Kvartalsrapport 2018-Q1
2018-05-11 - X-dag ordinarie utdelning HEART 0.00 SEK
2018-02-22 - Bokslutskommuniké 2017
2017-11-27 - Extra Bolagsstämma 2017
2017-11-23 - Kvartalsrapport 2017-Q3
2017-08-24 - Kvartalsrapport 2017-Q2
2017-05-31 - Kvartalsrapport 2017-Q1
2017-05-11 - X-dag ordinarie utdelning HEART 0.00 SEK
2017-05-10 - Årsstämma
2017-02-23 - Bokslutskommuniké 2016
2016-11-24 - Kvartalsrapport 2016-Q3
2016-08-25 - Kvartalsrapport 2016-Q2
2016-05-11 - Kvartalsrapport 2016-Q1
2016-05-10 - Årsstämma
2016-04-20 - X-dag ordinarie utdelning HEART 0.00 SEK
2016-02-18 - Bokslutskommuniké 2015
2015-11-12 - Kvartalsrapport 2015-Q3
2015-08-28 - Kvartalsrapport 2015-Q2
2015-05-26 - Kvartalsrapport 2015-Q1
2015-05-21 - X-dag ordinarie utdelning HEART 0.00 SEK
2015-05-20 - Årsstämma
2015-02-18 - Bokslutskommuniké 2014

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Scandinavian Real Heart är verksamt inom medicinteknik. Bolaget bedriver forskning och utveckling inom observationer av hjärtats fysiologi. Utvecklingen av bolagets produkt, ett komplett artificiellt hjärta, sker i samarbete med hjärtkirurger, forskare och ingenjörer. Fokus ligger på att utveckla patenterade lösningar som kan imitera det naturliga mänskliga hjärtats blodcirkulation, med mål att användas av patienter som diagnostiserats med hjärtsvikt. Bolaget grundades år 2007.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-01-28 17:23:00

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL.

Scandinavian Real Heart AB (publ) ("Realheart" or the "Company") has completed the rights issue of shares resolved by the Extra General Meeting on 16 December 2025 (the "Rights Issue"). The outcome shows that 2,502,531 shares were subscribed for with subscription rights, corresponding to approximately 50 percent of the Rights Issue. In addition, the Company has received subscription applications for 295,402 shares, corresponding to approximately 6 percent of the Rights Issue, for subscription without subscription rights. A total of 2,797,933 shares were subscribed for with subscription rights and subscription applications, corresponding to approximately 56 percent of the Rights Issue. This means that guarantee commitments of 701,160 shares, corresponding to approximately 14 percent of the Rights Issue, will be utilized. A total of 3,499,093 shares were thus subscribed, corresponding to approximately 70 percent of the Rights Issue. Through the Rights Issue, the Company will receive approximately SEK 49 million before issue costs.

On December 16, 2025, Realheart announced that the Extra General Meeting of the Company had resolved on a rights issue of shares of approximately SEK 70 million. The subscription price in the Rights Issue was SEK 14 per share and the total number of shares offered in the Rights Issue amounted to 4,998,704.

The outcome of the Rights Issue

The subscription period in the Rights Issue ended on January 27, 2026. The final outcome shows that 2,502,531 shares were subscribed for with subscription rights, which corresponds to approximately 50 percent of the Rights Issue. Furthermore, the Company has received subscription applications to subscribe for 295,402 shares without subscription rights, which corresponds to approximately 6 percent of the Rights Issue. Thus, 2,797,933 shares were subscribed for with and without subscription rights, corresponding to approximately 56 percent of the Rights Issue. Guarantee commitments of 701,160 shares will be exercised by the Company, corresponding to approximately 14 percent of the Rights Issue. A total of 3,499,093 shares were thus subscribed.

Through the Rights Issue, the Company will receive approximately SEK 49 million before issue costs.

Allotment of shares subscribed for without subscription rights

Allotment of shares subscribed for without subscription rights has been made in accordance with the principles set out in the Information Document published by the Company on 16 December 2025 in connection with the Rights Issue. Notification of such allocation will be notified separately by means of a settlement note. Nominee-registered shareholders will receive notification of allotment in accordance with instructions from the respective nominee.

Shares, share capital and dilution

Through the Rights Issue, the total number of shares in the Company will increase by 3,499,093 shares, from 4,998,704 shares to 8,497,797 shares, and the share capital will increase by SEK 17,530,455, from SEK 25,043,507 to SEK 42,573,962, corresponding to a dilution effect of 41.18 percent of the total number of shares and votes in the Company.

Trading in paid subscribed shares ("BTA")

Trading in BTA will take place until the conversion of BTA into shares, which will take place after the Rights Issue has been registered with the Swedish Companies Registration Office. Registration with the Swedish Companies Registration Office is expected to take place during week 8, 2026.

Compensation for subscription and guarantee commitments

In connection with the Rights Issue, the company received subscription and guarantee commitments. No compensation will be paid for subscription and guarantee commitments.

Issuing Institute

Nordic Issuing AB is the issuing agent in connection with the Rights Issue.